Trichostatin A - like Hydroxamate Histone Deacetylase Inhibitors as Therapeutic Agents: Toxicological Point of View

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|11|12|1629-1643

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.11, Iss.12, 2004-06, pp. : 1629-1643

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-hydroxamate Histone Deacetylase Inhibitors

By  

Current Medicinal Chemistry, Vol. 12, Iss. 24, 2005-11 ,pp. : 2867-2880

Bentham Science Publishers

Access to resources Recommend Favorite

Rational Design of Non-Hydroxamate Histone Deacetylase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 5, 2006-05 ,pp. : 515-526

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicological and metabolic considerations for histone deacetylase inhibitors

By Fraczek Joanna   Vanhaecke Tamara   Rogiers Vera  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 4, 2013-04 ,pp. : 441-457

Informa Healthcare

Access to resources Recommend Favorite

Histone deacetylase inhibitors: discovery and development as anticancer agents

By Marks Paul A   Dokmanovic Milos  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1497-1511

Informa Healthcare

Access to resources Recommend Favorite

Histone deacetylase inhibitors: novel anticancer agents

By Saunders N.A.   Popa C.   Serewko M.M.   Jones S.J.   Dicker A.J.   Dahler A.L.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1611-1621

Informa Healthcare

Access to resources Recommend Favorite